CLINICAL_TRIALS
trial_result
· 2017-05-30
Clinical Trial Update: Efficacy, Safety and Evolution of Cardiovascular Parameters in Renal Transplant Recipients [Phase 3]
Summary
Phase 3 trial update assessing efficacy, safety and cardiovascular parameters in kidney transplant recipients; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Kidney Transplantation | Phase 3 | Status: COMPLETED | Results posted: 2017-05-30